tiprankstipranks
Trending News
More News >
BeOne Medicines (ONC)
NASDAQ:ONC
US Market

BeOne Medicines (ONC) Income Statement

Compare
839 Followers

BeOne Medicines Income Statement

Last quarter (Q3 2025), BeOne Medicines's total revenue was $1.41B, an increase of 41.00% from the same quarter last year. In Q3, BeOne Medicines's net income was $124.84M. See BeOne Medicines’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 3.81B$ 2.46B$ 1.42B$ 1.18B$ 308.87M
Gross Profit
$ 3.22B$ 2.08B$ 1.13B$ 1.01B$ 238.22M
Operating Expenses
$ 3.78B$ 3.29B$ 2.92B$ 2.45B$ 1.90B
Depreciation and Amortization
$ 171.76M$ 87.67M$ 66.28M$ 46.46M$ 31.79M
EBITDA
$ -396.44M$ -1.12B$ -1.72B$ -1.39B$ -1.63B
Operating Income
$ -568.20M$ -1.21B$ -1.79B$ -1.44B$ -1.66B
Other Income/Expenses
$ 35.20M$ 381.90M$ -171.37M$ 147.00K$ 39.49M
Pretax Income
$ -533.00M$ -825.84M$ -1.96B$ -1.44B$ -1.62B
Net Income
$ -644.79M$ -881.71M$ -2.00B$ -1.46B$ -1.62B
Per Share Metrics
Basic EPS
$ -6.12$ -8.45$ -19.37$ -15.21$ -19.11
Diluted EPS
$ -6.12$ -8.45$ -19.37$ -15.21$ -19.11
Weighted Average Shares Outstanding
105.29M 104.39M 103.13M 92.79M 83.47M
Weighted Average Shares Outstanding (Diluted)
105.29M 104.39M 103.13M 92.79M 83.47M
Currency in USD

BeOne Medicines Earnings and Revenue History